Gartner Research

Hype Cycle for Life Science Manufacturing, Quality and Supply Chain, 2020

Published: 12 August 2020

ID: G00467845

Analyst(s): Michael Shanler , Stephen Meyer , Andrew Stevens


Life science manufacturers must continuously innovate and streamline processes for producing high-quality, regulated products. CIOs and IT leaders can use this Hype Cycle to identify opportunities and assess risks for technologies that enable quality, manufacturing and supply chain operations.

Table Of Contents


  • What You Need to Know
  • The Hype Cycle
  • The Priority Matrix
  • Off the Hype Cycle
  • On the Rise
    • Digital Life Science Platform (DLSP)
    • Cell and Gene Therapy Platform
    • Immersive AR/VR/MR Experiences in Life Science
  • At the Peak
    • IoT-Enabled Laboratory
    • Unique Device Identification
    • Blockchain in Life Sciences
    • Immersive Experience in Manufacturing Operations
  • Sliding Into the Trough
    • 3D Printed Drugs
    • Smart Factory
    • Predictive Analytics in Supply Chain Execution
    • Digital Twin
    • SaaS LIMS
    • Enterprise Laboratory Informatics
    • Quality by Design
    • SaaS ELN
    • Compliant GxP Cloud Services
    • MOM Application Suites
    • SaaS-Regulated CSP
  • Climbing the Slope
    • Asset Performance Management
    • Controlled Substance Ordering System
    • Pharma PLM
    • QMS Applications
    • Track and Trace and Serialization
    • Process Analytical Technology (PAT)
    • Electronic Batch Records
    • ELN
  • Appendixes
    • Hype Cycle Phases, Benefit Ratings and Maturity Levels

Gartner Recommended Reading

©2022 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.